Randomized trial reveals essential oil and herbal sachets improve sleep quality and anxiety in maintenance hemodialysis, indicating viable non-pharmacological symptom support.
Sleep disturbance and anxiety are common in maintenance hemodialysis patients, yet sustained non-pharmacological management remains difficult in routine dialysis care. This single-center, open-label, parallel-group randomized trial evaluated whether a combined olfactory intervention using an essential-oil preparation and a traditional Chinese herbal sachet was associated with improved self-reported sleep quality and anxiety. Eighty-eight eligible patients with a baseline Pittsburgh Sleep Quality Index (PSQI) score >7 were recruited from Yongkang Hospital of Traditional Chinese Medicine between January 2022 and December 2023 and randomized 1:1 by random-number table to usual care or usual care plus the combined intervention. The trial was not prospectively registered, and participant and intervention-provider blinding was not feasible because of the odor-based intervention. The essential-oil preparation contained lavender essential oil, bergamot essential oil, and coconut oil in a 5:3:10 ratio and was used during dialysis and before sleep; the herbal sachet was placed near the pillow and replaced monthly. Outcomes were assessed using the PSQI and Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) at baseline, day 7, day 15, month 1, and month 3. The primary endpoint was the between-group difference in PSQI global score at month 3. At month 3, the intervention group had lower PSQI scores than the control group (7.8 ± 2.6 vs 13.8 ± 2.5; adjusted β, -5.37; 95% CI, -6.29 to -4.45; P < 0.001) and lower HADS-A scores (9.2 ± 2.1 vs 11.8 ± 2.4; adjusted β, -2.61; 95% CI, -3.26 to -1.96; P < 0.001). Sleep response occurred in 77.3% versus 31.8%, and anxiety response occurred in 68.2% versus 29.5%. Mean adherence was 86.7% for bedtime application and 83.4% for dialysis-session inhalation. Any adverse event was reported in 15.9% versus 6.8%, with no serious intervention-related adverse events. These preliminary findings require confirmation in larger controlled multicenter trials.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: